Drug-induced Iatrogenic Intraparenchymal Hemorrhage

This section is compiled by Frank M. Painter, D.C.
Send all comments or additions to:    Frankp@chiro.org

FROM:   Neurosurg Clin N Am 2002 (Jul); 13 (3): 299–312

Lapsiwala S, Moftakhar R, Badie B

Department of Neurosurgery,
University of Wisconsin Hospital and Clinics,
600 Highland Avenue, H4/3 CSC,
Madison, WI 53792, USA.
Lapsi@neurosurg.wisc.edu

---

Intracerebral hemorrhage is bleeding into the brain parenchyma with possible extension into the ventricles and subarachnoid space. Each year, approximately 37,000 to 52,400 people suffer from intraparenchymal hemorrhage (IPH) in the United States. This rate is expected to rise dramatically in the next few decades as a result of the increasing age of the population and a change in racial demographics. IPH accounts for 8% to 13% of all stroke cases and is associated with the highest mortality rate.

Return to PHARMACY

Return to IATROGENIC INJURY

Since 12-20-2002